448 related articles for article (PubMed ID: 28664939)
1. Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms.
Onaindia A; Medeiros LJ; Patel KP
Mod Pathol; 2017 Oct; 30(10):1338-1366. PubMed ID: 28664939
[TBL] [Abstract][Full Text] [Related]
2. Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets.
Bogusz AM; Bagg A
Leuk Lymphoma; 2016 Sep; 57(9):1991-2013. PubMed ID: 27121112
[TBL] [Abstract][Full Text] [Related]
3. CLLU1 expression distinguishes chronic lymphocytic leukemia from other mature B-cell neoplasms.
Oppliger Leibundgut E; Rogenmoser-Dissler D; de Beer D; Porret NA; Zibellini S; Dürig J; Röth A; Klingbiel D; Baerlocher GM
Leuk Res; 2012 Sep; 36(9):1204-7. PubMed ID: 22738889
[TBL] [Abstract][Full Text] [Related]
4. Indolent lymphomas of mature B lymphocytes.
Kurtin PJ
Hematol Oncol Clin North Am; 2009 Aug; 23(4):769-90. PubMed ID: 19577169
[TBL] [Abstract][Full Text] [Related]
5. Exome sequencing identifies recurrent
Jallades L; Baseggio L; Sujobert P; Huet S; Chabane K; Callet-Bauchu E; Verney A; Hayette S; Desvignes JP; Salgado D; Levy N; Béroud C; Felman P; Berger F; Magaud JP; Genestier L; Salles G; Traverse-Glehen A
Haematologica; 2017 Oct; 102(10):1758-1766. PubMed ID: 28751561
[TBL] [Abstract][Full Text] [Related]
6. Quantitative assessment of informative immunophenotypic markers increases the diagnostic value of immunophenotyping in mature CD5-positive B-cell neoplasms.
Starostka D; Kriegova E; Kudelka M; Mikula P; Zehnalova S; Radvansky M; Papajik T; Kolacek D; Chasakova K; Talianova H
Cytometry B Clin Cytom; 2018 Jul; 94(4):576-587. PubMed ID: 29220870
[TBL] [Abstract][Full Text] [Related]
7. New developments in non-Hodgkin lymphoid malignancies.
Ganapathi KA; Brown LE; Prakash S; Bhargava P
Pathology; 2021 Apr; 53(3):349-366. PubMed ID: 33685720
[TBL] [Abstract][Full Text] [Related]
8. Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia.
Capello D; Vitolo U; Pasqualucci L; Quattrone S; Migliaretti G; Fassone L; Ariatti C; Vivenza D; Gloghini A; Pastore C; Lanza C; Nomdedeu J; Botto B; Freilone R; Buonaiuto D; Zagonel V; Gallo E; Palestro G; Saglio G; Dalla-Favera R; Carbone A; Gaidano G
Blood; 2000 Jan; 95(2):651-9. PubMed ID: 10627476
[TBL] [Abstract][Full Text] [Related]
9. Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia/small lymphocytic lymphoma in small B-cell lymphomas.
Tandon B; Peterson L; Gao J; Nelson B; Ma S; Rosen S; Chen YH
Mod Pathol; 2011 Nov; 24(11):1433-43. PubMed ID: 21685909
[TBL] [Abstract][Full Text] [Related]
10. Utility of quantitative flow cytometry immunophenotypic analysis of CD5 expression in small B-cell neoplasms.
Challagundla P; Jorgensen JL; Kanagal-Shamanna R; Gurevich I; Pierson DM; Ferrajoli A; Reyes SR; Medeiros LJ; Miranda RN
Arch Pathol Lab Med; 2014 Jul; 138(7):903-9. PubMed ID: 24978916
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic utility of the B-cell lineage markers CD20, CD79a, PAX5, and CD19 in paraffin-embedded tissues from lymphoid neoplasms.
Adams H; Liebisch P; Schmid P; Dirnhofer S; Tzankov A
Appl Immunohistochem Mol Morphol; 2009 Mar; 17(2):96-101. PubMed ID: 18838917
[TBL] [Abstract][Full Text] [Related]
12. Primary nodal marginal zone lymphomas of splenic and MALT type.
Campo E; Miquel R; Krenacs L; Sorbara L; Raffeld M; Jaffe ES
Am J Surg Pathol; 1999 Jan; 23(1):59-68. PubMed ID: 9888704
[TBL] [Abstract][Full Text] [Related]
13. The combined expression of VPREB3 and ID3 represents a new helpful tool for the routine diagnosis of mature aggressive B-cell lymphomas.
Soldini D; Georgis A; Montagna C; Schüffler PJ; Martin V; Curioni-Fontecedro A; Martinez A; Tinguely M
Hematol Oncol; 2014 Sep; 32(3):120-5. PubMed ID: 24493312
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin gene analysis of mature B-cell malignancies: reconsideration of cellular origin and potential antigen involvement in pathogenesis.
Walsh SH; Rosenquist R
Med Oncol; 2005; 22(4):327-41. PubMed ID: 16260850
[TBL] [Abstract][Full Text] [Related]
15. Genetic aberrations of signaling pathways in lymphomagenesis: revelations from next generation sequencing studies.
Rossi D; Ciardullo C; Gaidano G
Semin Cancer Biol; 2013 Dec; 23(6):422-30. PubMed ID: 23665546
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Myocyte Enhancer Factor 2B Versus Other Germinal Center-associated Antigens in the Differential Diagnosis of B-Cell Non-Hodgkin Lymphomas.
Moore EM; Swerdlow SH; Gibson SE
Am J Surg Pathol; 2018 Mar; 42(3):342-350. PubMed ID: 29309299
[TBL] [Abstract][Full Text] [Related]
17. Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases.
Camacho FI; Mollejo M; Mateo MS; Algara P; Navas C; Hernández JM; Santoja C; Solé F; Sánchez-Beato M; Piris MA
Am J Surg Pathol; 2001 Oct; 25(10):1268-76. PubMed ID: 11688461
[TBL] [Abstract][Full Text] [Related]
18. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas.
Dogan A; Bagdi E; Munson P; Isaacson PG
Am J Surg Pathol; 2000 Jun; 24(6):846-52. PubMed ID: 10843287
[TBL] [Abstract][Full Text] [Related]
19. Frequent p53 gene involvement in splenic B-cell leukemia/lymphomas of possible marginal zone origin.
Baldini L; Fracchiolla NS; Cro LM; Trecca D; Romitti L; Polli E; Maiolo AT; Neri A
Blood; 1994 Jul; 84(1):270-8. PubMed ID: 8018922
[TBL] [Abstract][Full Text] [Related]
20. BRAF V600E is also seen in unclassifiable splenic B-cell lymphoma/leukemia, a potential mimic of hairy cell leukemia.
Raess PW; Mintzer D; Husson M; Nakashima MO; Morrissette JJ; Daber R; Bagg A
Blood; 2013 Oct; 122(17):3084-5. PubMed ID: 24159168
[No Abstract] [Full Text] [Related]
[Next] [New Search]